Science

Another psychedelic revolution, but this time it’s different

We cannot know the future, but there are a number of reasons to believe that psychedelic medicine really can break out of its ghetto and into the mainstream … What must not be allowed to happen is for these promising and much-needed drugs to fail for anything other than the purest of scientific reasons.

More still needs to be done. The law remains excessively tight: psychedelics are still schedule 1 drugs, which means they have no acknowledged uses in medicine. The onus is on scientists to show conclusively that they do. Some of the scientists also need to embrace the system rather than pushing against it. Talk to many a psychedelics researcher and it doesn’t take long to hear complaints of risk-averse funders and regulators. Enough. The outlaw-maverick pose was once an asset in this field; it [may also been seen as a liability through some lenses]. It may transpire that, as with so many drugs, the early promise melts away under the glare of full-scale clinical trials. Such is life in pharma research.

Original Article (New Scientist):
Another psychedelic revolution, but this time it’s different
Artwork Fair Use: National Institutes of Health

Psychology

…for macrodosing

Politics

First, it was weed…

Politics

Manufacturing…

Spirituality

…the Mushroom

Politics

Oregon psilocybin…

Science

What is kratom…?

Politics

SITSA … stopped

Politics

Grassy Globes

Politics

Weed wages water war

Politics

Big acid

Politics

Can Kratom be patented?

Science

Kratom LD-50 Stats

Science

Rolling in the deep

Science

The Peace Drug

Leave a Reply